Dergiler / Eurasian Journal of Medicine and Oncology / 2020 / Cilt: 4 - Sayı: 3

Epitope-Based Vaccine Design against Novel Coronavirus SARS-CoV-2 Envelope Protein

Sayfa
201–208
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Epitopes were thus identified and some of them can be potential candidates for vaccine development.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: The outbreak of the 2019 novel coronavirus (SARS-CoV-2) has infected millions of people with a large number of deaths across 200 countries.
📊
Temel Bulgular & Veri:The sudden appearance of the virus leads to the limited existing therapies for SARS-CoV-2.
💡
Sonuç & Katkı:Conclusion: Epitopes were thus identified and some of them can be potential candidates for vaccine development.
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: The outbreak of the 2019 novel coronavirus (SARS-CoV-2) has infected millions of people with a large number of deaths across 200 countries. The sudden appearance of the virus leads to the limited existing therapies for SARS-CoV-2. Therefore, vaccines and antiviral medicines are in desperate need. Methods: This study took immune-informatics approaches to identify B- and T-cell epitopes for envelope membrane protein (E) of SARS-CoV-2, followed by estimating their antigenicity and interactions with the human leukocyte antigen (HLA) alleles. Results: We identified three B cell epitopes (“NSSRVPD”, “SRVKNLNSSRV”, “SRVPDLLV”), two MHC class-I (“FLLVTLAIL”, “VSLVKPSFY”) and one MHC class-II binding T-cell epitopes (“LLFLAFVVFLLVTLA”), which showed highly antigenic features. Allergenicity, toxicity and physicochemical properties analysis confirmed the specificity and selectivity of epitopes. The stability and safety of epitopes were confirmed by digestion analysis. Conclusion: Epitopes were thus identified and some of them can be potential candidates for vaccine development.

🔖

Bu Makaleye Atıf Yap

DAGUR, H. S., DHAKAR, S. S., GUPTA, A. (2020). Epitope-Based Vaccine Design against Novel Coronavirus SARS-CoV-2 Envelope Protein. Eurasian Journal of Medicine and Oncology, Cilt: 4 - Sayı: 3, 201–208. https://ajindex.com/articles/124575

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Coronavirus Update (Live): 2,359,346 Cases and 161,975 Deaths from COVID-19 Virus Pandemic - Worldometer [Internet]. [cited 2020 Apr 20]. p. 1. Available from: www.worldometers.info/coronavirus/ 2. Dagur HS, Dhakar SS. Genome Organization of Covid-19 and Emerging Severe Acute Respiratory Syndrome Covid-19 Outbreak: A Pandemic. Eurasian J Med Oncol. 2020
  2. 4(December 2019):107–15. 3. Jiaxin Zhou, Peng Wu. Correspondence Detection of Covid-19 in Children in Early January 2020 in Wuhan, China. N Engl J Med. 2020
  3. 2019–21. 4. Chan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet [Internet]. 2020
  4. 395(10223):514– 23. Available from: http://dx.doi.org/10.1016/S0140- 6736(20)30154-9 5. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet [Internet]. 2020
  5. 395(10223):507–13. Available from: http://dx.doi.org/10.1016/S0140-6736(20)30211-7 6. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020
  6. 382(13):1199–207. 7. Lindenbach BD, Rice CM. Molecular biology of flaviviruses. Adv Virus Res. 2003
  7. 23–61. 8. Schoeman D, Fielding BC. Coronavirus envelope protein: Current knowledge. Virol J. 2019
  8. 16(1):1–22. 9. Bianchi M, Benvenuto D, Giovanetti M, Angeletti S, Pascarella S. Sars-CoV-2 Envelope and Membrane proteins: differences from closely related proteins linked to cross-species transmission ? 2020
  9. (April). 10. Tahir Ul Qamar M, Bari A, Adeel MM, Maryam A, Ashfaq UA, Du X, et al. Peptide vaccine against chikungunya virus: Immunoinformatics combined with molecular docking approach. J Transl Med [Internet]. 2018
  10. 16(1):1–14. Available from: https:// doi.org/10.1186/s12967-018-1672-7 11. Seema M. T Cell Epitope-Based Vaccine Design for Pandemic Novel Coronavirus 2019-nCoV. Chemrxiv [Internet]. 2020
  11. Available from: https://chemrxiv.org/articles/T_Cell_ Epitope-Based_Vaccine_Design_for_Pandemic_Novel_ Coronavirus_2019-nCoV/12029523 12. Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Res. 2018
  12. 46(W1):W296–303. 13. Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bair